TD Cowen Reiterates Buy on Revolution Medicines, Announces $250 Price Target

Benzinga · 3d ago
TD Cowen analyst Tyler Van Buren reiterates Revolution Medicines (NASDAQ:RVMD) with a Buy and announces $250 price target.